Strategic Advocates LLC Dexcom Inc Transaction History
Strategic Advocates LLC
- $279 Billion
- Q3 2024
A detailed history of Strategic Advocates LLC transactions in Dexcom Inc stock. As of the latest transaction made, Strategic Advocates LLC holds 4,472 shares of DXCM stock, worth $324,354. This represents 0.11% of its overall portfolio holdings.
Number of Shares
4,472
Previous 6,279
28.78%
Holding current value
$324,354
Previous $712 Million
57.89%
% of portfolio
0.11%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding DXCM
# of Institutions
1,029Shares Held
355MCall Options Held
3.81MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA47.4MShares$3.44 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.5 Billion0.09% of portfolio
-
Capital Research Global Investors Los Angeles, CA17.9MShares$1.3 Billion0.26% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.18 Billion0.08% of portfolio
-
Baillie Gifford & CO15MShares$1.09 Billion0.77% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $28B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...